1. The search for an ideal oral positive inotropic agent

   • L. B. Tan

   Editorial Pages: 509 - 512

2. Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes

   • WHO Drug Utilization Research Group (DURG)
   • K. Griffiths
   • B. E. Wiholm

   Originals Pages: 513 - 519

3. Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension

   • WHO Drug Utilization Research Group (DURG)
   • K. Griffiths
   • L. Wilhelmsen

   Originals Pages: 521 - 525

4. Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication

   • W. Schaumann
   • B. Kaufmann
   • A. Smolarz

   Originals Pages: 527 - 533

5. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension

   • T. Dyckner
   • P.-O. Wester
   • L. Widman

   Originals Pages: 535 - 540

6. Studies on the antihypertensive effect of single doses of the angiotensin converting enzyme inhibitor ramipril (HOE 498) in man

   • R. O. B. Böhm
   • M. A. van Baak
   • K. H. Rahn

   Originals Pages: 541 - 547

7. Pharmacodynamics and pharmacokinetics of three different doses of urapidil infused in hypertensive patients

   • R. Kirsten
   • K. Nelson
   • H. W. Radtke

   Originals Pages: 549 - 552

8. Evaluation of once daily endralazine in hypertension

   • R. Wu
   • J. D. Spence
   • S. G. Carruthers

   Originals Pages: 553 - 557

9. The effect of bucindolol on the airway function of asthmatics

   • R. E. Ruffin
   • A. J. Crockett
   • J. H Alpers

   Originals Pages: 559 - 565

10. Potential pulmonary uptake and clearance of morphine in postoperative patients

    • M. P. Persson
    • L. Wiklund
    • L. Paalzow

    Originals Pages: 567 - 574

11. Rate-limiting diffusion processes following intrathecal administration of morphine

    • P. Sandouk
    • J. M. Scherrmann
    • M. Chauvin

    Originals Pages: 575 - 579

12. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration

    • W. H. Aellig
    • J. Rosenthaler

    Originals Pages: 581 - 584

13. Clonazepam pharmacokinetics and therapeutic efficacy in neonatal seizures

    • M. André
    • M. J. Boutroy
    • P. L. Morselli

    Originals Pages: 585 - 589

14. Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease

    • M. Lázníček
    • K. E. O. Senius

    Originals Pages: 591 - 596

15. Dosage adjustment for ceftazidime in patients with impaired renal function

    • R. van Dalen
    • T. B. Vree
    • E. Termond

    Originals Pages: 597 - 605

16. Effect of acarbose on carbohydrate tolerance during administration of a fibre-free formula diet on healthy subjects

    • I. E. Walter-Sack
    • A. Ittner-Holland
    • N. Zoellner

    Originals Pages: 607 - 614

17. Pharmacokinetics of fluocortolone in man

    • U. F. Legler

    Originals Pages: 615 - 617

18. Lack of effect of cimetidine on pharmacodynamics and kinetics of single oral doses of R- and S-acenocoumarol

    • H. H. W. Thijssen
    • G. M. J. Janssen
    • L. G. M. Baars

    Originals Pages: 619 - 623

19. Influence of topical beclomethasone dipropionate suspension on human nasal mucociliary activity

    • K. Holmberg
    • U. Pipkorn

    Short Communications Pages: 625 - 627

20. Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administration

    • S. Eksborg
    • U. Stendahl
    • U. Lönroth

    Short Communications Pages: 629 - 631

21. Interaction between cyclosporin and erythromycin in a kidney transplant patient

    • M. Kessler
    • J. Louis
    • P. Netter

    Letters To The Editors Pages: 633 - 634

22. Diurnal variation in the pharmacokinetics of intravenous theophylline and etophylline in healthy subjects

    • B. L. Chauhan
    • B. S. Doshi
    • R. D. Kulkarni

    Letters To The Editors Pages: 635 - 636